• FirefoxUpgrade to the new Firefox »
  •  Dow Up1.73% Nasdaq Up1.86%

    Catalyst Pharmaceutical Partners Inc. (CPRX)

    -NasdaqCM
    2.85 Down 0.02(0.80%) 1:47PM EST - Nasdaq Real Time Price
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
    Total Revenue -   -   -  
    Cost of Revenue -   -   -  
    Gross Profit -   -   -  
    Operating Expenses
    Research Development8,097  2,660  3,384  
    Selling General and Administrative2,215  2,562  2,698  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (10,312) (5,221) (6,082)
    Income from Continuing Operations
    Total Other Income/Expenses Net(1,843)1,145  (309)
    Earnings Before Interest And Taxes(12,155)(4,076)(6,391)
    Interest Expense -   -   -  
    Income Before Tax(12,155)(4,076)(6,391)
    Income Tax Expense -   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(12,155)(4,076)(6,391)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (12,155) (4,076) (6,391)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (12,155) (4,076) (6,391)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.